• 11/25/2024

Prologue Journal

Understanding current events through the lenses of the past and future.

USA

Genmab to Boost Oncology Portfolio With ProfoundBio Buy

Wall Street Journal

Danish biotech Genmab will buy U.S.-based ProfoundBio for $1.8 billion in cash as it looks to bolster its pipeline of cancer treatments.

https://www.wsj.com/articles/genmab-strengthens-oncology-portfolio-with-1-8-bln-acquisition-of-profoundbio-b121c371